Single-center, noninterventional clinical trial to assess the safety, efficacy, and tolerability of a dimeticone-based medical device in facilitating the removal of scales after topical application in patients with psoriasis corporis or psoriasis capitis

INTRODUCTION: Psoriasis is a frequent inflammatory skin disease affecting ~2%–3% of the population in western countries. Scaling of the psoriatic lesions is the most impairing symptom in patients with psoriasis. In contrast to conventional keratolytic treatment concepts containing salicylic acid or...

Descripción completa

Detalles Bibliográficos
Autores principales: Hengge, Ulrich R, Röschmann, Kristina, Candler, Henning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774606/
https://www.ncbi.nlm.nih.gov/pubmed/29387607
http://dx.doi.org/10.2147/PTT.S130295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774606/
https://www.ncbi.nlm.nih.gov/pubmed/29387607
http://dx.doi.org/10.2147/PTT.S130295

Ejemplares similares